Skip to content

A pilot study to assess the influence of drug transporters on brain and organ distribution of erlotinib in humans

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-516550-21-00
Enrollment
87
Registered
2024-12-11
Start date
2015-06-26
Completion date
Unknown
Last updated
2024-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

None listed

Sponsors

Medical University Of Vienna
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Austria

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026